Skip to content

Clinical trials

Phase 3 Heart Failure trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Phase 3 Country / region: Sweden Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20032
20051
20063
20072
20081
20091
20131
20144
20151
20161
20173
20184
20202
20241
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Recruiting7
Terminated4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Novartis Pharmaceuticals4
Boehringer Ingelheim3
Amgen2
Bayer2
Lexicon Pharmaceuticals2
Sanofi2
Alnylam Pharmaceuticals1
Biogen1
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure35
Heart Diseases3
Myocardial Infarction3
Cardiovascular Diseases2
Coronary Artery Disease2
Diabetes Mellitus, Type 22
Heart Failure, Diastolic2
Renal Insufficiency2
Stroke2
Ventricular Dysfunction, Left2

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.